Cargando…

Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy

Apo2 ligand (Apo2L, also known as TRAIL) is a member of the tumour necrosis factor (TNF) family of cytokines that selectively induces the death of cancer cells, but not of normal cells. We observed that recombinant Apo2L/TRAIL was proapoptotic in early-passage BTK-143 osteogenic sarcoma cells, induc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bouralexis, S, Findlay, D M, Atkins, G J, Labrinidis, A, Hay, S, Evdokiou, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Experimental Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394221/ https://www.ncbi.nlm.nih.gov/pubmed/12838325 http://dx.doi.org/10.1038/sj.bjc.6601021

Ejemplares similares

Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis
por: Liang, Chaojie, et al.
Publicado: (2017)

Membrane expression of TRAIL receptors DR4, DR5, DcR1 and DcR2 in the normal endometrium, atypical endometrial hyperplasia and endometrioid adenocarcinoma: a tissue microarray study
por: Gottwald, Leszek, et al.
Publicado: (2013)

TRAIL and DcR1 Expressions Are Differentially Regulated in the Pancreatic Islets of STZ- versus CY-Applied NOD Mice
por: Dirice, Ercument, et al.
Publicado: (2011)

Upregulated TRAIL and Reduced DcR2 Mediate Apoptosis of Decidual PMN-MDSC in Unexplained Recurrent Pregnancy Loss
por: Li, Congcong, et al.
Publicado: (2020)

Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis
por: Vindrieux, David, et al.
Publicado: (2011)

PTHrP Overexpression Increases Sensitivity of Breast Cancer Cells to Apo2L/TRAIL
por: Cheung, Vanessa, et al.
Publicado: (2013)

HIF-1α Mediates TRAIL-Induced Neuronal Apoptosis via Regulating DcR1 Expression Following Traumatic Brain Injury
por: Fang, Yuanjian, et al.
Publicado: (2020)

GATA4 and DcR1 methylation in glioblastomas
por: Vaitkienė, Paulina, et al.
Publicado: (2013)

Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis
por: Su, Jingqian, et al.
Publicado: (2023)

N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
por: Dufour, Florent, et al.
Publicado: (2017)

TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes
por: Staniek, Julian, et al.
Publicado: (2019)

N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
por: Estornes, Yann, et al.
Publicado: (2018)

Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
por: Grinkevitch, Vera, et al.
Publicado: (2022)

TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill
por: Mohr, Andrea, et al.
Publicado: (2015)

TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells
por: Cantarella, G, et al.
Publicado: (2006)

Overexpression of DcR3 and Its Significance on Tumor Cell Differentiation and Proliferation in Glioma
por: Huang, Suning, et al.
Publicado: (2014)

DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin
por: Gao, Liqin, et al.
Publicado: (2017)

Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model
por: Liu, Yi-Ling, et al.
Publicado: (2017)

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs
por: Ashley, D M, et al.
Publicado: (2008)

TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress
por: Dufour, Florent, et al.
Publicado: (2016)

Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells
por: Ucur, E, et al.
Publicado: (2003)

Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines
por: van Geelen, C M M, et al.
Publicado: (2003)

Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib
por: Lecis, D, et al.
Publicado: (2010)

TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population
por: Loebinger, M R, et al.
Publicado: (2010)

Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
por: Degli-Esposti, Mariapia A., et al.
Publicado: (1997)

Targeting Death Receptor TRAIL-R2 by Chalcones for TRAIL-Induced Apoptosis in Cancer Cells
por: Szliszka, Ewelina, et al.
Publicado: (2012)

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
por: Tuthill, Mark H, et al.
Publicado: (2014)

α-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells
por: Tomasetti, M, et al.
Publicado: (2004)

Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice
por: Ganai, S, et al.
Publicado: (2009)

Absolute quantification of DcR3 and GDF15 from human serum by LC-ESI MS
por: Lancrajan, Ioana, et al.
Publicado: (2015)

DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis
por: Li, Junxin, et al.
Publicado: (2017)

Btk Is Required for an Efficient Response to Erythropoietin and for SCF-controlled Protection against TRAIL in Erythroid Progenitors
por: Schmidt, Uwe, et al.
Publicado: (2004)

Apoptosis induction in renal cell carcinoma by TRAIL and γ-radiation is impaired by deficient caspase-9 cleavage
por: Ramp, U, et al.
Publicado: (2003)

TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt
por: Szegezdi, E, et al.
Publicado: (2006)

Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines
por: Mahalingam, D, et al.
Publicado: (2009)

Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015)

Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody
por: Martini, Silvia, et al.
Publicado: (2020)

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
por: Rambow, Anna-Christina, et al.
Publicado: (2022)

DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma in Northeast Chinese women
por: Fu, Zhenkun, et al.
Publicado: (2016)

Up-regulation of DcR3 in microbial toxins-stimulated HUVECs involves NF-κB signalling
por: Hou, Yanqiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r3kf52tikrcmph6t7tdvej3ub1